Citius Pharma(CTXR) - 2024 Q4 - Annual Results

Exhibit 99.1 Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update Clinical and regulatory success in 2024 expected to drive value in 2025 CRANFORD, N.J., December 27, 2024 -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended Septemb ...